Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 5, 2010, Pages

  Amu, Sylvie ^a   Saunders, Sean P ^a   Kronenberg, Mitchell ^b   Mangan, Niamh E ^a   Atzberger, Ann ^a   Fallon, Padraic G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

asthma; CD1d; helminth; IL 10; inflammation; Mouse; regulatory B cell; regulatory T cell

Indexed keywords

CD19 ANTIGEN; CD1D ANTIGEN; INTERLEUKIN 10; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; LUNG INFILTRATE; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 77951667958     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.01.018     Document Type: Article

References (71)

1. Devereux G. The increase in the prevalence of asthma and allergy: food for thought. Nat Rev Immunol 6 (2006) 869-874
2. Yazdanbakhsh M., Kremsner P.G., and van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 296 (2002) 490-494
3. Fallon P.G., and Mangan N.E. Suppression of TH2-type allergic reactions by helminth infection. Nat Rev Immunol 7 (2007) 220-230
4. Umetsu D.T., McIntire J.J., Akbari O., Macaubas C., and DeKruyff R.H. Asthma: an epidemic of dysregulated immunity. Nat Immunol 3 (2002) 715-720
5. Anthony R.M., Rutitzky L.I., Urban Jr. J.F., Stadecker M.J., and Gause W.C. Protective immune mechanisms in helminth infection. Nat Rev Immunol 7 (2007) 975-987
6. Maizels R.M., Balic A., Gomez-Escobar N., Nair M., Taylor M.D., and Allen J.E. Helminth parasites-masters of regulation. Immunol Rev 201 (2004) 89-116
7. Hawrylowicz C.M., and O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 5 (2005) 271-283
8. Akdis C.A., and Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 123 (2009) 735-746 quiz 47-8
9. Mangan N.E., Fallon R.E., Smith P., van Rooijen N., McKenzie A.N., and Fallon P.G. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol 173 (2004) 6346-6356
10. Mangan N.E., van Rooijen N., McKenzie A.N., and Fallon P.G. Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J Immunol 176 (2006) 138-147
11. Mizoguchi A., Mizoguchi E., Takedatsu H., Blumberg R.S., and Bhan A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16 (2002) 219-230
12. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., and Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28 (2008) 639-650
13. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., and Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118 (2008) 3420-3430
14. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., and Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3 (2002) 944-950
15. Rafei M., Hsieh J., Zehntner S., Li M., Forner K., Birman E., et al. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat Med 15 (2009) 1038-1045
16. Mauri C., Gray D., Mushtaq N., and Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197 (2003) 489-501
17. Evans J.G., Chavez-Rueda K.A., Eddaoudi A., Meyer-Bahlburg A., Rawlings D.J., Ehrenstein M.R., et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 178 (2007) 7868-7878
18. Blair P.A., Chavez-Rueda K.A., Evans J.G., Shlomchik M.J., Eddaoudi A., Isenberg D.A., et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 182 (2009) 3492-3502
19. Smith P., Walsh C.M., Mangan N.E., Fallon R.E., Sayers J.R., McKenzie A.N., et al. Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J Immunol 173 (2004) 1240-1248
20. Kearley J., Robinson D.S., and Lloyd C.M. CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 122 (2008) 617-624 e6
21. Fallon P.G., Sasaki T., Sandilands A., Campbell L.E., Saunders S.P., Mangan N.E., et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41 (2009) 602-608
22. Finkelman F.D. Use of unrestrained, single-chamber barometric plethysmography to evaluate sensitivity to cholinergic stimulation in mouse models of allergic airway disease. J Allergy Clin Immunol 121 (2008) 334-335
23. Szalay G., Ladel C.H., Blum C., Brossay L., Kronenberg M., and Kaufmann S.H. Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta 2 and Th1 cytokines and ameliorates listeriosis in mice. J Immunol 162 (1999) 6955-6958
24. Smith P., Mangan N.E., Walsh C.M., Fallon R.E., McKenzie A.N., van Rooijen N., et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 178 (2007) 4557-4566
25. Baban B., Chandler P.R., Sharma M.D., Pihkala J., Koni P.A., Munn D.H., et al. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 183 (2009) 2475-2483
26. Baban B., Hansen A.M., Chandler P.R., Manlapat A., Bingaman A., Kahler D.J., et al. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int Immunol 17 (2005) 909-919
27. Kamanaka M., Kim S.T., Wan Y.Y., Sutterwala F.S., Lara-Tejero M., Galan J.E., et al. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25 (2006) 941-952
28. Mauri C., and Ehrenstein M.R. The "short" history of regulatory B cells. Trends Immunol 29 (2008) 34-40
29. Brossay L., Jullien D., Cardell S., Sydora B.C., Burdin N., Modlin R.L., et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol 159 (1997) 1216-1224
30. Borg N.A., Wun K.S., Kjer-Nielsen L., Wilce M.C., Pellicci D.G., Koh R., et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448 (2007) 44-49
31. Mallevaey T., Zanetta J.P., Faveeuw C., Fontaine J., Maes E., Platt F., et al. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni. J Immunol 176 (2006) 2476-2485
32. Mallevaey T., Fontaine J., Breuilh L., Paget C., Castro-Keller A., Vendeville C., et al. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis. Infect Immun 75 (2007) 2171-2180
33. Matangkasombut P., Pichavant M., Dekruyff R.H., and Umetsu D.T. Natural killer T cells and the regulation of asthma. Mucosal Immunol 2 (2009) 383-392
34. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278 (1997) 1623-1626
35. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
36. Gorelik L., and Flavell R.A. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12 (2000) 171-181
37. Leslie M. I. Take-charge B cells create a buzz. Science 325 (2009) 144-145
38. Boyton R. The role of natural killer T cells in lung inflammation. J Pathol 214 (2008) 276-282
39. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., and Van Kaer L. NKT cells: what's in a name?. Nat Rev Immunol 4 (2004) 231-237
40. Meyer E.H., DeKruyff R.H., and Umetsu D.T. T cells and NKT cells in the pathogenesis of asthma. Annu Rev Med 59 (2008) 281-292
41. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 9 (2003) 582-588
42. Koh Y.I., Kim H.Y., Meyer E.H., Pichavant M., Akbari O., Yasumi T., et al. Activation of nonclassical CD1d-restricted NK T cells induces airway hyperreactivity in beta 2-microglobulin-deficient mice. J Immunol 181 (2008) 4560-4569
43. Meyer E.H., Goya S., Akbari O., Berry G.J., Savage P.B., Kronenberg M., et al. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc Natl Acad Sci U S A 103 (2006) 2782-2787
44. Matsuda H., Suda T., Sato J., Nagata T., Koide Y., Chida K., et al. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am J Respir Cell Mol Biol 33 (2005) 22-31
45. Morishima Y., Ishii Y., Kimura T., Shibuya A., Shibuya K., Hegab A.E., et al. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. Eur J Immunol 35 (2005) 2803-2814
46. Hachem P., Lisbonne M., Michel M.L., Diem S., Roongapinun S., Lefort J., et al. Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma. Eur J Immunol 35 (2005) 2793-2802
47. Fujita H., Teng A., Nozawa R., Takamoto-Matsui Y., Katagiri-Matsumura H., Ikezawa Z., et al. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model. J Immunol 183 (2009) 254-260
48. Barrett N.A., and Austen K.F. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 31 (2009) 425-437
49. Renukaradhya G.J., Khan M.A., Vieira M., Du W., Gervay-Hague J., and Brutkiewicz R.R. Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma. Blood 111 (2008) 5637-5645
50. Terabe M., and Berzofsky J.A. The role of NKT cells in tumor immunity. Adv Cancer Res 101 (2008) 277-348
51. Yanaba K., Bouaziz J.D., Matsushita T., Tsubata T., and Tedder T.F. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 182 (2009) 7459-7472
52. Bialecki E., Paget C., Fontaine J., Capron M., Trottein F., and Faveeuw C. Role of marginal zone B lymphocytes in invariant NKT cell activation. J Immunol 182 (2009) 6105-6113
53. Sonoda K.H., and Stein-Streilein J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol 32 (2002) 848-857
54. Lang G.A., Illarionov P.A., Glatman-Freedman A., Besra G.S., and Lang M.L. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. Int Immunol 17 (2005) 899-908
55. Barral P., Eckl-Dorna J., Harwood N.E., De Santo C., Salio M., Illarionov P., et al. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc Natl Acad Sci U S A 105 (2008) 8345-8350
56. Leadbetter E.A., Brigl M., Illarionov P., Cohen N., Luteran M.C., Pillai S., et al. NK T cells provide lipid antigen-specific cognate help for B cells. Proc Natl Acad Sci U S A 105 (2008) 8339-8344
57. Smits H.H., Gloudemans A.K., van Nimwegen M., Willart M.A., Soullie T., Muskens F., et al. Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. Mucosal Immunol 2 (2009) 331-339
58. Chen X., and Jensen P.E. Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells. J Immunol 179 (2007) 2046-2050
59. Shah S., and Qiao L. Resting B cells expand a CD4+CD25+Foxp3+ Treg population via TGF-beta3. Eur J Immunol 38 (2008) 2488-2498
60. Mann M.K., Maresz K., Shriver L.P., Tan Y., and Dittel B.N. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol 178 (2007) 3447-3456
61. McMillan S.J., Xanthou G., and Lloyd C.M. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol 174 (2005) 5774-5780
62. Presser K., Schwinge D., Wegmann M., Huber S., Schmitt S., Quaas A., et al. Coexpression of TGF-beta1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivity. J Immunol 181 (2008) 7751-7758
63. Kearley J., Barker J.E., Robinson D.S., and Lloyd C.M. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 202 (2005) 1539-1547
64. Singh A., Carson W., Secor Jr. E.R., Guernsey L.A., Flavell R.A., Clark R.B., et al. Regulatory role of B cells in a murine model of allergic airway disease. J Immunol 180 (2008) 7318-7326
65. van den Biggelaar A.H., van Ree R., Rodrigues L.C., Lell B., Deelder A.M., Kremsner P.G., et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356 (2000) 1723-1727
66. Medeiros Jr. M., Figueiredo J.P., Almeida M.C., Matos M.A., Araujo M.I., Cruz A.A., et al. Schistosoma mansoni infection is associated with a reduced course of asthma. J Allergy Clin Immunol 111 (2003) 947-951
67. Smits H.H., Hammad H., van Nimwegen M., Soullie T., Willart M.A., Lievers E., et al. Protective effect of Schistosoma mansoni infection on allergic airway inflammation depends on the intensity and chronicity of infection. J Allergy Clin Immunol 120 (2007) 932-940
68. Correale J., Farez M., and Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 64 (2008) 187-199
69. Madan R., Demircik F., Surianarayanan S., Allen J.L., Divanovic S., Trompette A., et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol 183 (2009) 2312-2320
70. Holt P.G., Sly P.D., Martinez F.D., Weiss S.T., Bjorksten B., von Mutius E., et al. Drug development strategies for asthma: in search of a new paradigm. Nat Immunol 5 (2004) 695-698
71. Fallon P.G., and Alcami A. Pathogen-derived immunomodulatory molecules: future immunotherapeutics?. Trends Immunol 27 (2006) 470-476